Michael Adam Gordon serves as Executive at Lucid Diagnostics Inc., where they oversee executive responsibilities. Since joining the company, Michael Adam Gordon has executed 2 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Sep 30, 2025 involved receiving (via award) 150,000 shares valued at $0.
Michael Adam Gordon currently holds 150,000 shares of Lucid Diagnostics Inc. (LUCD), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Michael Adam Gordon has been a net neutral trader of LUCD stock. They have purchased $0 and sold $0 worth of shares.
Michael Adam Gordon's most recent insider trade was on Sep 30, 2025, when they sold 150,000 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |